During the past decade, Institute for Respiratory Health conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 4 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institute for Respiratory Health" #1 sponsor was "Vertex Pharmaceuticals Incorporated" with 6 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute for Respiratory Health" #1 collaborator was "Concord Hospital" with 1 trials as a collaborator, "Fiona Stanley Hospital" with 1 trials as a collaborator, "Guy's and St Thomas' NHS Foundation Trust" with 1 trials as a collaborator, "Hollywood Private Hospital, Australia" with 1 trials as a collaborator and "Northern Hospital, Australia" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Institute for Respiratory Health" are "Cystic Fibrosis" (6 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Asthma" (1 trials), "Bronchiectasis" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "Institute for Respiratory Health" in a lesser frequency.

Most popular intervention types in "Institute for Respiratory Health" are "Drug" (12 trials), "Other" (4 trials), "Biological" (3 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "ELX/TEZ/IVA" (6 trials), "IVA" (6 trials), "Lebrikizumab" (2 trials) and "0.9% Sodium Chloride for Injection, USP" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute for Respiratory Health" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Institute for Respiratory Health". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Institute for Respiratory Health, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Institute for Respiratory Health, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".